Sector Update: Health Care
Scilex Says US Bankruptcy Court Extends Lockup Period on Stock Dividend to Sorrento Shareholders
Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025
Express News | Scilex Holding Company Announces That the U.S. Bankruptcy Court Has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to Its Stockholders as a Dividend to January 31, 2025
Sector Update: Health Care Stocks Decline Monday Afternoon
Scilex Holding to Pay $2 Million to Oramed Pharmaceuticals in Loan Accord
Express News | Oramed Pharmaceuticals Inc: Scilex to Pay $2 Mln to Co. Under Letter Agreement
Sword of Justice! The US FTC sues three major pharmaceutical "middlemen", vows to correct the distorted profit chain.
The USA's FTC announced on its official website that it has filed a lawsuit against three major "pharmacy benefit managers" and their affiliated organizations, accusing them of engaging in anti-competitive and unfair kickback practices. FTC also "clearly stated" in the declaration its deep concern about the roles played by eli lilly and co, novo-nordisk a/s, sanofi, and other insulin pharmaceutical companies, and the competition bureau may recommend prosecuting these pharmaceutical companies in future enforcement actions.
Express News | Scilex Holding Company Announces the Continuing Support From Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of Fsf 33433 LLC $10 Million Loan
Scilex Holding Co Announces It Has Received the Drug Distributor Accreditation From The National Association Of Boards Of Pharmacy
Private Companies Account for 46% of Scilex Holding Company's (NASDAQ:SCLX) Ownership, While Institutions Account for 22%
Denali Capital Acquisition Deposits $15K Into Trust Account To Fund Extension Until October 11, 2024; Funded Via Convertible Promissory Note With Scilex Holding Company For Up To $180K, Convertible Into Class A Shares At $10 Per Share
Top 3 Health Care Stocks That Could Blast Off In September
Scilex Holding Company To Present "Prophylaxis Of Gout Flares In Patients With Renal Impairment: Dosing Adjustments With Colchicine Oral Solution Informed By A Pharmacokinetic Model" At The 2024 American College Of Rheumatology Convergence Conference...
Express News | Denali Capital Acquisition: Combined Co to Be Renamed Semnur Pharmaceuticals, Inc., Common Stock to Be Listed on Nasdaq Under Ticker Symbols "Smnr"
Express News | Denali Capital Acquisition: Scilex Expected to Be Majority Holder of Combined Co Following Completion of Deal
Express News | Denali Capital Acquisition Corp: Pre-Transaction Equity Value of Semnur at $2.5 Bln
Express News | Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: Deca) Announce Signing of a Merger Agreement for a Proposed Business Combination
Scilex Holding Announces FDA Final Approval To Precision Dosing For GLOPERBA Label
Express News | Scilex Holding Company Announces FDA Final Approval to Precision Dosing for Gloperba® Label